N/A N=54 Ketamine Infusion and Hypoventilation
Hypoventilation
Primary: Intraoperative Hypoventilation — 1.2; 65 % time
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=40 A Comparison of the Detection of Hypoventilation During Deep Sedation Utilizing Nasal End Title CO@ Versus Transcutaneous CO2 Measurement Techniques
Surgery · Hypoventilation
Primary: TcCo2 vs PACo2 Difference — 3.2 mmHG
N/A N=65 Impact of Head of Bed Elevation in Symptoms of Patients With Gastroesophageal Reflux Disease
Gastroesophageal Reflux Disease
Primary: Change in Reflux Disease Questionnaire Scores Administered at Baseline and 6 Weeks After Each Intervention — -1.2397; 0.0869 scores on a scale — p=0.0002
N/A N=23 Autotitrating Versus Standard Non-invasive Ventilation (NIV) in Newly Diagnosed Patients
Nocturnal Hypoventilation · Neuromuscular Disease · Chest Wall Disorder
Primary: Overnight Mean Oxygen Saturation — 96; 96 % SaO2 — p=0.13
N/A N=167 Using Capnography to Reduce Hypoxia During Pediatric Sedation
Hypoventilation · Hypoxia
Primary: Frequency of Staff Interventions for Hypoventilation. — 0.39; 0.396 Events per patient minute of sedation
Phase 3 N=33 Reduction of Night-time Blood Pressure in Pediatric Renal Transplant Recipients
Hypertension Secondary to Kidney Transplant
Primary: Number of Participants Who Are Non Dippers — 7; 12 Participants
N/A N=99 Determination of the Predictors of Nocturnal Desaturation in Postpartum Women
Sleep Disordered Breathing · Nocturnal Oxygen Desaturation · Upper Airway Edema
Primary: SpO2 < 90% — 0.4; 0.0; 0.1; 0.0 minutes
N/A N=105 Effect of Use of DryNites Absorbent Pants on the Rate of Spontaneous Resolution of Paediatric Nocturnal Enuresis (NE)
Nocturnal Enuresis
Primary: Wet Nights — 2.4; 4.6 wet nights per week
Phase 3 N=125 6-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 Diabetes
Type 1 Diabetes Mellitus
Primary: Event Rate of "All Hypoglycemia" Defined as the Total Number of Episodes Divided by the Total Duration of the On-treatment Period in Years (Events Per Patient-year)…
N/A N=12 Scheduled Awakenings for the Treatment of Nocturnal Enuresis
Nocturnal Enuresis
Primary: Change in Number of Dry Nights When Using the Scheduled Awakening Protocol With the Lully Sleep Guardian — -0.67 difference in number of dry nights
N/A N=7 Response to Albuterol Delivered Through an Anti-static Valved Holding Chamber During Nocturnal Bronchospasm
Asthma
Primary: Y=100([FEV1 at 1 Puffs-FEV1 at 4AM)/FEV1@4AM] Difference Period 2 Minus Period 1. — -15.4; 26.7 percentage of change from 4AM — p=0.026
N/A N=17 Effects of Compression Stockings on Obstructive Sleep Apnea in Patients Under Hemodialysis
Renal Failure Chronic Requiring Dialysis · Obstructive Sleep Apnea
Primary: Change of Obstructive Apnea Severity Index Score From Baseline — 20.8; 16.7 events/hour
Phase 4 N=157 Study to Evaluate the Effects of Synthetic Conjugated Estrogens, B (SCE-B) on Nocturnal Vasomotor Symptoms in Postmenopausal Women
Nocturnal Vasomotor Symptoms
Primary: Mean Change in Average Frequency of Awakenings Due to Sleep-time Hot Flashes — -19.54; -20.55; -15.99 Awakenings
N/A N=32 Overnight Pant Study for Children With Nocturnal Enuresis
Nocturnal Enuresis
Primary: Number, Frequency and Severity of Product Related Adverse Events — 47; 63; 110; 5 Number of product related Adverse Events
Phase 4 N=18 Ravulizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria Currently Treated With High-Dose Eculizumab
Paroxysmal Nocturnal Hemoglobinuria
Primary: Percentage of Participants Who Experienced Free C5-associated BTH — 0 percentage of participants